ProfileGDS4459 / ENSG00000116984
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 70% 76% 78% 64% 76% 76% 71% 79% 78% 76% 76% 77% 79% 68% 73% 76% 77% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 15.2570
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.5476
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 36.0878
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 4564
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 55.7576
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.6976
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.5171
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 86.0779
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 9678
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.876
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.7376
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.9777
GSM623476group B, liver allograft wedge biopsie placebo treatment 36.0179
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.0768
GSM623478group B, liver allograft wedge biopsie placebo treatment 55.6873
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.5876
GSM623480group B, liver allograft wedge biopsie placebo treatment 75.777